Search

Your search keyword '"Kallay, Krisztian"' showing total 25 results

Search Constraints

Start Over You searched for: Author "Kallay, Krisztian" Remove constraint Author: "Kallay, Krisztian"
25 results on '"Kallay, Krisztian"'

Search Results

1. Next-Generation Sequencing–Based Genomic Profiling of Children with Acute Myeloid Leukemia

2. Second allogeneic stem cell transplantation can rescue a significant proportion of patients with JMML relapsing after first allograft

3. Safety and efficacy of rivaroxaban in pediatric cerebral venous thrombosis (EINSTEIN-Jr CVT): for the EINSTEIN-Jr Cerebral Venous Thrombosis trial investigators

4. Rivaroxaban compared with standard anticoagulants for the treatment of acute venous thromboembolism in children: a randomised, controlled, phase 3 trial

5. Bodyweight-adjusted rivaroxaban for children with venous thromboembolism (EINSTEIN-Jr): results from three multicentre, single-arm, phase 2 studies

7. P6 - NPM1 MUTATIONS IN CHILDREN WITH MYELODYSPLASTIC SYNDROME WITH EXCESS BLASTS

8. OC 20 - GENOTYPE/PHENOTYPE ASSOCIATIONS IN 174 INDIVIDUALS WITH GERMLINE GATA2 MUTATIONS

11. Rivaroxaban compared with standard anticoagulants for the treatment of acute venous thromboembolism in children: a randomised, controlled, phase 3 trial

12. A Retrospective Study on Inotuzumab Ozogamicin in Infants and Young Children with Relapsed or Refractory Acute Lymphoblastic Leukemia (ALL)

13. Children and Adults with Refractory Acute Graft-versus-Host Disease Respond to Treatment with the Mesenchymal Stromal Cell Preparation MSC-FFM-Outcome Report of 92 Patients

14. 2012 – ADAPTIVE AND MALADAPTIVE SOMATIC RESCUE MOSAICISM IN SAMD9 AND SAMD9L SYNDROMES EXEMPLIFIES THE HIGH PLASTICITY OF HEMATOPOIESIS EARLY IN LIFE

15. Effective treatment of steroid and therapy-refractory acute graft-versus-host disease with a novel mesenchymal stromal cell product (MSC-FFM)

16. Children and Adults with Steroid-Refractory Acute Graft-Versus-Host Disease Respond to Treatment with the Mesenchymal Stroma Cell Preparation MSC-FFM: Treatment Results for 92 Consecutive Patients

18. Excellent response, low TRM and good survival in patients with therapy-refractory aGvHD after treatment with potency-defined doses of MSCs generated from a serum-free MSC-BANK of pooled BM-MNCS from multiple healthy donors

19. SAMD9 and SAMD9L Germline Disorders in Patients Enrolled in Studies of the European Working Group of MDS in Childhood (EWOG-MDS): Prevalence, Outcome, Phenotype and Functional Characterisation

20. Systematic Assessment of GATA2 Genetic Variation Reveals the Presence of Novel Disease-Causing Synonymous Exonic Mutations

21. Treatment of Patients with Therapy-Refractory Acute GvHD with the Novel MSC Product “MSC-Ffm” Resulted in Excellent Response and Low Mortality: Post-Approval Observational Data from 69 Consecutive Patients

23. LB12 - Excellent response, low TRM and good survival in patients with therapy-refractory aGvHD after treatment with potency-defined doses of MSCs generated from a serum-free MSC-BANK of pooled BM-MNCS from multiple healthy donors

24. Familial AML With Germline CEBPA Mutations: Extended Clinical Outcomes and Analysis Of Secondary Mutations Using Whole Exome Sequencing

25. Familial AML With Germline CEBPAMutations: Extended Clinical Outcomes and Analysis Of Secondary Mutations Using Whole Exome Sequencing

Catalog

Books, media, physical & digital resources